Lentigen Technology

Industry / private company


Location: Gaithersburg, United States (USA) (US) US

ROR: https://ror.org/0333j1f77

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A Phase I Open Label Dose Escalation Study of MB-CART19.1 in Relapsed and Refractory CD19+B Cell Malignancies, Interim Preliminary Results in Pediatric ALL, Adult ALL Including CLL Cohorts (2021) Mackensen A, Hanssens L, Stelljes M, Bethge WA, Feuchtinger T, Kuenkele A, Aigner M, et al. Conference contribution